- Pacific Biosciences of California Inc.
- Complete Genomics Inc.
- Illumina Inc.
- Life Technologies Corp.
- National Human Genome Research Institute
- National Institutes of Health
- Affymetrix Inc.
- eBioscience Inc.
- Novartis AG
- Genoptix Inc.
- Clarient Inc.
- GE Healthcare
- General Electric Co.
- Nestle SA
- Nestle Health Science SA
- Prometheus Laboratories Inc.
- Procter & Gamble Co.
- Pfizer Inc.
- Genentech Inc.
- Abbott Laboratories Inc.
- Institut Merieux
- bioMerieux SA
- Ortho Biotech Oncology Research & Development
- Johnson & Johnson
- Pacific Biosciences nets $186mm via its IPO
- IPO nets $50.2mm for Complete Genomics
- Affymetrix to acquire eBioscience for $330mm cash; companies later decide on $315mm
- Novartis buys Genoptix for $440mm; Genoptix sold off
- GE to buy Clarient for $587mm
- Nestle boosts personalized nutritionals initiative with Prometheus buy
- Abbott to develop companion Dx for Pfizer's NSCLC candidate
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.